Therapeutic Efficiency of Nasal Mucosa-Derived Ectodermal Mesenchymal Stem Cells in Rats with Acute Hepatic Failure.

Wen XiangXinhe WangXinghui YuYan XieLi ZhangNai-Yan Lu Wentao Jiang

Published in: Stem cells international (2023)

These results confirmed the feasibility of EMSCs in acute hepatic failure treatment. To our knowledge, this is the first time that EMSCs are used in the therapy of liver diseases. EMSCs are expected to be a novel and promising cell source in liver tissue engineering.

Keyphrases

tissue engineering
liver failure
mesenchymal stem cells
respiratory failure
cell therapy
drug induced
aortic dissection
healthcare
single cell
hepatitis b virus
stem cells
bone marrow
extracorporeal membrane oxygenation
intensive care unit
mechanical ventilation
acute respiratory distress syndrome